Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of Targeted Temperature Management With Whole Body Hypothermia For Moderate And Severe Hypoxic-Ischemic Encephalopathy In Premature Infants 33-35 Weeks Gestational Age.

NCT01793129 is registered in ClinicalTrials.gov with NICHD Neonatal Research Network as lead sponsor.

NCT NCT01793129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01793129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of Targeted Temperature Management With Whole Body Hypothermia For Moderate And Severe Hypoxic-Ischemic Encephalopathy In Premature Infants 33-35 Weeks Gestational Age.
Lead sponsor
NICHD Neonatal Research Network
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2015
Completion date
December 9, 2022
Enrollment
168 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

encephalopathy, hypoxic-ischemic, hypoxia, brain, hypoxia-ischemia, brain, hypoxic-ischemic encephalopathy, infant, newborn, ischemic-hypoxic encephalopathy